EU’s Pharma Package falls short of Europe’s goal of global competitiveness
Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some experts.
AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline
Piramal Pharma announces $90m investment to expand US sites
FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency
Vetter breaks ground on $285m US clinical manufacturing site
WHO accuses China of withholding Covid-19 genetic data
Analysis
View More
Themes
View MoreLisata collaborates with GATC Health on drug development
Lisata will utilise GATC's Multiomics Advanced Technology platform.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI act
Next-generation targeting for evolving HCP engagement
Are regulators keeping pace with AI adoption in clinical trials?